Masami Takeuchi

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Alteration of enzyme specificity by computational loop remodeling and design

Epidemiology of Invasive Mycoses in North America

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE

Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

Management of patients with hepatitis B who require immunosuppressive therapy

The Performance of Real-Time PCR, Galactomannan, and Fungal Culture in the Diagnosis of Invasive Aspergillosis in Ventilated Patients with Chronic Obstructive Pulmonary Disease (COPD)

First report of pulmonary Nocardia otitidiscaviarum infection in an immunocompetent patient from Turkey

Galactomannan detection for invasive aspergillosis in immunocompromized patients

American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis

Candida albicanspathogenicity mechanisms

Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?

Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma

Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury

Changing epidemiology of systemic fungal infections

Invasive aspergillosis in patients with liver disease

Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted Therapy

Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney

Accuracy of BAL Galactomannan in Diagnosing Invasive Aspergillosis

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Prevention and Treatment of Cancer-Related Infections

Hepatitis B reactivation in HBsAg‐negative/HBcAb‐positive patients receiving rituximab for lymphoma: a meta‐analysis

Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B

Low Rates of Hepatitis B Virus Screening at the Onset of Chemotherapy

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta‐analysis

Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome

Clinical and Laboratory Features of theNocardiaspp. Based on Current Molecular Taxonomy

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Breakthrough Trichosporonosis in Patients with Hematologic Malignancies Receiving Micafungin

Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients

Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

High frequency of neurolymphomatosis as a relapse disease of intravascular large B‐cell lymphoma

Reactivation of hepatitis B virus after rituximab‐containing treatment in patients with CD20‐positive B‐cell lymphoma

Successful Treatment of Breakthrough Trichosporon asahii Fungemia with Voriconazole in a Patient with Acute Myeloid Leukemia

Reversal of dialysis-dependent renal failure in patients with advanced multiple myeloma: single institutional experiences over 8 years

[Pulmonary Nocardia otitidiscaviarum infection in an immunocompetent host].

[Analysis of serum Aspergillus galactomannan contents conducted at our hospital during the past 2 years].